Table 3.

Clinical Outcomes in Patients with Moderate-Risk TA-TMA

Outcome	Value
MODS, n (%)	19 (42.2)
PICU admission, n (%)	26 (54.2)
RRT, n (%)	9 (18.8)
Lowest cystC GFR in patients without RRT, mL/min, median (range)	50 (30.8–65.5)
Refractory hypertension requiring continuous medication infusion, n (%)	3 (6.2)
Pericardial effusion requiring medical interventions, n (%)	8 (16.7)
Pericardial effusion requiring pericardiocentesis due to tamponade, n (%)	2 (4.9)
Mechanical ventilation, n (%)	17 (35.4)
Pulmonary hypertension, n (%)	1 (2.1)
Seizures and posterior reversible encephalopathy syndrome, n (%)	3 (6.2)
Altered mental status, n (%)	6 (12.5)
Intestinal bleeding, n (%)	5 (10.4)
Intestinal stricture, n (%)	1 (2.1)
BSI, n (%)	26 (54.2)
Fungal infection, n (%)	3 (6.2)
BKPyV viremia, n (%)	19 (43.2)
CMV viremia, n (%)	13 (27.1)
EBV viremia, n (%)	13 (27.1)
Adenoviremia, n (%)	12 (25)
Acute GVHD, n (%)
Grade I	3 (6.5)
Grade II	3 (6.5)
Grade III	4 (8.7)
Grade IV	2 (4.3)

RRT indicates renal replacement therapy.